NUVB - Nuvation Bio Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$13.00
DETAILS
HIGH:
$17.00
LOW:
$10.00
MEDIAN:
$12.50
CONSENSUS:
$13.00
UPSIDE:
175.42%
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||
| Revenue | 62.9 | 7.9 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | 8.4 | 7.1 | 0 | 0 | 0 | 0.1 | 0 | 0 |
| Gross Profit | 54.5 | 0.8 | 0 | 0 | 0 | (0.1) | 0 | 0 |
| Operating Expenses | ||||||||
| R&D Expenses | 115.1 | 524.2 | 71.3 | 87.8 | 69.0 | 32.6 | 25.1 | 0.5 |
| SG&A Expenses | 151.6 | 69.2 | 28.5 | 31.9 | 24.3 | 10.8 | 7.0 | 0.5 |
| Other Expenses | 0.9 | 0 | 0 | 0 | 0 | 0 | (0.0) | 0 |
| Operating Expenses | 267.5 | 593.4 | 99.8 | 119.7 | 93.3 | 43.4 | 32.1 | 1.0 |
| Operating Income | ||||||||
| Operating Income | (213.1) | (592.6) | (99.8) | (119.7) | (93.3) | (43.6) | (32.1) | (1.0) |
| Interest Expense | 13.7 | 0.3 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Income | 21.4 | 27.1 | 24.6 | 7.4 | 3.0 | 1.9 | 0.0 | 0 |
| Profitability | ||||||||
| EBITDA | (190.9) | (566.9) | (75.6) | (119.5) | (93.1) | (41.6) | (32.1) | 0 |
| EBIT | (190.9) | (567.6) | (75.8) | (119.7) | (93.3) | (41.7) | (32.1) | (1.0) |
| Income Before Tax | (204.6) | (567.9) | (75.8) | (104.2) | (86.8) | (41.7) | (33.6) | (1.0) |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income | (204.6) | (567.9) | (75.8) | (104.2) | (86.8) | (41.7) | (33.6) | (1.0) |
| Per Share Data | ||||||||
| EPS (Basic) | -0.60 | -2.11 | -0.35 | -0.48 | -0.44 | -0.19 | -0.16 | -0.01 |
| EPS (Diluted) | -0.60 | -2.11 | -0.35 | -0.48 | -0.44 | -0.19 | -0.16 | -0.01 |
| Shares Outstanding | 341.5 | 268.8 | 218.9 | 216.7 | 197.9 | 217.7 | 206.7 | 183.7 |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| Current Assets | ||||||||
| Cash & Cash Equivalents | 164.1 | 35.7 | 42.6 | 101.1 | 132.4 | 29.8 | 3.5 | 0.1 |
| Short-Term Investments | 365.1 | 467.0 | 568.6 | 559.9 | 633.0 | 186.0 | 115.4 | 0 |
| Net Receivables | 19.4 | 16.3 | 3.7 | 2.5 | 3.0 | 1.1 | 0 | 0 |
| Inventory | 11.4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 11.5 | 7.3 | 1.5 | 3.8 | 0 | 2.9 | 0.8 | 0 |
| Total Current Assets | 571.5 | 526.3 | 616.4 | 667.3 | 772.1 | 220.7 | 119.9 | 0.2 |
| Non-Current Assets | ||||||||
| Property, Plant & Equipment | 4.5 | 3.0 | 4.3 | 4.7 | 3.7 | 0.7 | 0.6 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 11.2 | 4.6 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 7.6 | 6.8 | 0.7 | 0.1 | 0.4 | 0.4 | 0.4 | 0 |
| Total Non-Current Assets | 23.3 | 14.4 | 5.0 | 4.8 | 4.1 | 1.1 | 1.1 | 0 |
| Total Assets | 594.8 | 540.6 | 621.5 | 672.1 | 776.2 | 221.8 | 121.0 | 0.2 |
| Current Liabilities | ||||||||
| Account Payables | 9.5 | 6.3 | 2.2 | 2.1 | 3.9 | 2.2 | 2.0 | 0.1 |
| Short-Term Debt | 7.6 | 6.3 | 0 | 0 | 0 | 0 | 0 | 0.6 |
| Deferred Revenue | 0 | 11.1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 65.1 | 14.8 | 4.3 | 4.0 | 6.2 | 3.2 | 0.0 | 0 |
| Total Current Liabilities | 82.2 | 58.2 | 14.0 | 13.2 | 16.9 | 6.6 | 3.2 | 0.9 |
| Non-Current Liabilities | ||||||||
| Long-Term Debt | 2.5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 58.5 | 2.1 | 0.4 | 0.8 | 11.0 | 0.2 | 0 | 0 |
| Total Non-Current Liabilities | 206.9 | 18.6 | 2.4 | 3.9 | 13.2 | 0.2 | 0 | 0 |
| Total Liabilities | 289.1 | 76.8 | 16.4 | 17.1 | 30.2 | 6.7 | 3.2 | 0.9 |
| Stockholders' Equity | ||||||||
| Common Stock | 1,421.3 | 1,374.0 | 947.7 | 927.6 | 910.0 | 289.5 | 9.8 | 0 |
| Retained Earnings | (1,115.4) | (910.7) | (342.8) | (267.0) | (162.8) | (76.0) | (34.3) | (0.7) |
| Accumulated Other Comprehensive Income | (0.2) | 0.6 | 0.2 | (5.5) | (1.2) | 1.6 | 0.4 | 0 |
| Total Stockholders' Equity | 305.7 | 463.8 | 605.1 | 655.1 | 746.0 | 215.1 | 117.7 | (0.7) |
| Total Liabilities & Equity | 594.8 | 540.6 | 621.5 | 672.1 | 776.2 | 221.8 | 121.0 | 0.2 |
| Debt Metrics | ||||||||
| Total Debt | 10.1 | 8.9 | 4.0 | 4.3 | 3.1 | 0 | 0 | 0.6 |
| Net Debt | (153.9) | (26.8) | (38.6) | (96.8) | (129.4) | (29.8) | (3.5) | 0.5 |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | (204.6) | (567.9) | (75.8) | (104.2) | (86.8) | (41.7) | (33.6) | (1.0) |
| Depreciation & Amortization | 1.7 | 0.7 | 0.2 | 0.2 | 0.2 | 0.1 | 0.0 | 0 |
| Stock-Based Compensation | 0 | 32.3 | 19.5 | 16.3 | 9.3 | 2.2 | 0 | 0 |
| Change in Working Capital | (12.0) | (12.5) | 0.5 | (3.4) | 4.8 | 2.1 | (0.5) | 0.3 |
| Other Non-Cash Items | 41.4 | 417.1 | (12.5) | (5.0) | 4.4 | 0.7 | 9.6 | 0.1 |
| Operating Cash Flow | (173.4) | (130.4) | (68.0) | (96.1) | (68.2) | (36.5) | (24.4) | (0.6) |
| Investing Activities | ||||||||
| Capital Expenditure | (0.4) | (0.2) | (0.1) | (0.4) | (0.3) | (0.1) | (0.7) | 0 |
| Acquisitions | 0 | 12.4 | 0 | 0 | 0 | (2.5) | 0 | 0 |
| Purchases of Investments | (354.4) | (339.6) | (703.4) | (520.3) | (609.3) | (143.3) | 0 | 0 |
| Sales/Maturities of Investments | 462.3 | 450.1 | 712.3 | 584.1 | 154.9 | 73.1 | 0 | 0 |
| Other Investing Activities | 0 | 0 | 0.0 | 0.0 | 0 | 2.5 | (115.2) | 0 |
| Investing Cash Flow | 99.5 | 122.7 | 8.9 | 63.5 | (454.7) | (70.3) | (115.9) | 0 |
| Financing Activities | ||||||||
| Net Debt Issuance | 191.1 | (4.6) | 0 | 0 | 0 | 0 | 15.0 | 0 |
| Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0 | 0 | 0.6 | 1.3 | 625.5 | (2.5) | 128.6 | 0.8 |
| Financing Cash Flow | 202.5 | 0.3 | 0.6 | 1.3 | 625.5 | 133.1 | 143.6 | 0.8 |
| Cash Position | ||||||||
| Net Change in Cash | 128.4 | (6.9) | (58.5) | (31.3) | 102.7 | 26.3 | 3.3 | 0.2 |
| Cash at Beginning | 35.7 | 42.6 | 101.1 | 132.4 | 29.8 | 3.5 | 0.1 | 0 |
| Cash at End | 164.1 | 35.7 | 42.6 | 101.1 | 132.4 | 29.8 | 3.5 | 0.2 |
| Free Cash Flow | (173.8) | (130.6) | (68.1) | (96.5) | (68.5) | (36.7) | (25.1) | (0.6) |
| Key Metrics | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 62.9 | 7.9 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | 54.5 | 0.8 | 0 | 0 | 0 | (0.1) | 0 | 0 |
| Operating Income | (213.1) | (592.6) | (99.8) | (119.7) | (93.3) | (43.6) | (32.1) | (1.0) |
| Net Income | (204.6) | (567.9) | (75.8) | (104.2) | (86.8) | (41.7) | (33.6) | (1.0) |
| EPS (Diluted) | -0.60 | -2.11 | -0.35 | -0.48 | -0.44 | -0.19 | -0.16 | -0.01 |
| Balance Sheet | ||||||||
| Cash & Equivalents | 164.1 | 35.7 | 42.6 | 101.1 | 132.4 | 29.8 | 3.5 | 0.1 |
| Total Assets | 594.8 | 540.6 | 621.5 | 672.1 | 776.2 | 221.8 | 121.0 | 0.2 |
| Total Debt | 10.1 | 8.9 | 4.0 | 4.3 | 3.1 | 0 | 0 | 0.6 |
| Stockholders' Equity | 305.7 | 463.8 | 605.1 | 655.1 | 746.0 | 215.1 | 117.7 | (0.7) |
| Cash Flow | ||||||||
| Operating Cash Flow | (173.4) | (130.4) | (68.0) | (96.1) | (68.2) | (36.5) | (24.4) | (0.6) |
| Capital Expenditure | (0.4) | (0.2) | (0.1) | (0.4) | (0.3) | (0.1) | (0.7) | 0 |
| Free Cash Flow | (173.8) | (130.6) | (68.1) | (96.5) | (68.5) | (36.7) | (25.1) | (0.6) |